Circulating levels of FGF-21 decreased significantly following a 1-year lifestyle intervention program together with the reduction of BMI Z score, leptin and FFAs but independently of the amelioration of any parameter of the MetS, NAFLD and body composition [14]. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.